nodes	percent_of_prediction	percent_of_DWPC	metapath
Bimatoprost—AKR1C3—obesity	0.656	1	CbGaD
Bimatoprost—PTGFR—ovarian follicle—obesity	0.0232	0.39	CbGeAlD
Bimatoprost—PTGER3—respiratory system—obesity	0.00383	0.0644	CbGeAlD
Bimatoprost—PTGFR—respiratory system—obesity	0.00306	0.0515	CbGeAlD
Bimatoprost—AKR1C3—islet of Langerhans—obesity	0.00264	0.0443	CbGeAlD
Bimatoprost—PTGER3—adipose tissue—obesity	0.00259	0.0435	CbGeAlD
Bimatoprost—PTGER3—digestive system—obesity	0.00244	0.0409	CbGeAlD
Bimatoprost—PTGER3—adrenal gland—obesity	0.00232	0.039	CbGeAlD
Bimatoprost—PTGER1—endocrine gland—obesity	0.0023	0.0386	CbGeAlD
Bimatoprost—AKR1C3—adrenal cortex—obesity	0.00209	0.0351	CbGeAlD
Bimatoprost—PTGFR—adipose tissue—obesity	0.00207	0.0348	CbGeAlD
Bimatoprost—PTGER3—endocrine gland—obesity	0.00201	0.0338	CbGeAlD
Bimatoprost—PTGFR—adrenal gland—obesity	0.00186	0.0312	CbGeAlD
Bimatoprost—AKR1C3—pituitary gland—obesity	0.00169	0.0284	CbGeAlD
Bimatoprost—AKR1C3—adipose tissue—obesity	0.00168	0.0282	CbGeAlD
Bimatoprost—PTGFR—endocrine gland—obesity	0.00161	0.027	CbGeAlD
Bimatoprost—AKR1C3—adrenal gland—obesity	0.00151	0.0253	CbGeAlD
Bimatoprost—PTGFR—liver—obesity	0.00145	0.0244	CbGeAlD
Bimatoprost—Latanoprost—SLC22A1—obesity	0.0012	0.488	CrCbGaD
Bimatoprost—AKR1C3—liver—obesity	0.00118	0.0198	CbGeAlD
Bimatoprost—Tension—Phenylpropanolamine—obesity	0.000815	0.00671	CcSEcCtD
Bimatoprost—Nervousness—Phenylpropanolamine—obesity	0.000806	0.00664	CcSEcCtD
Bimatoprost—Urine abnormality—Topiramate—obesity	0.000806	0.00664	CcSEcCtD
Bimatoprost—Dyspepsia—Methamphetamine—obesity	0.000795	0.00654	CcSEcCtD
Bimatoprost—Insomnia—Benzphetamine—obesity	0.000787	0.00648	CcSEcCtD
Bimatoprost—Cystitis noninfective—Sibutramine—obesity	0.000785	0.00646	CcSEcCtD
Bimatoprost—Vision blurred—Phenylpropanolamine—obesity	0.000783	0.00644	CcSEcCtD
Bimatoprost—Tension—Phentermine—obesity	0.00078	0.00642	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Methamphetamine—obesity	0.000779	0.00641	CcSEcCtD
Bimatoprost—Cystitis—Sibutramine—obesity	0.000776	0.00639	CcSEcCtD
Bimatoprost—Nervousness—Phentermine—obesity	0.000772	0.00635	CcSEcCtD
Bimatoprost—Dyspepsia—Benzphetamine—obesity	0.000766	0.00631	CcSEcCtD
Bimatoprost—Cough increased—Bupropion—obesity	0.000766	0.0063	CcSEcCtD
Bimatoprost—Lacrimation increased—Bupropion—obesity	0.00076	0.00626	CcSEcCtD
Bimatoprost—Urine analysis abnormal—Topiramate—obesity	0.000759	0.00625	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Benzphetamine—obesity	0.000751	0.00619	CcSEcCtD
Bimatoprost—Dry eye—Sibutramine—obesity	0.000742	0.00611	CcSEcCtD
Bimatoprost—Hypercholesterolaemia—Bupropion—obesity	0.000741	0.0061	CcSEcCtD
Bimatoprost—Bladder pain—Sibutramine—obesity	0.000727	0.00598	CcSEcCtD
Bimatoprost—Insomnia—Phendimetrazine—obesity	0.000718	0.00591	CcSEcCtD
Bimatoprost—Anxiety—Phenylpropanolamine—obesity	0.000704	0.0058	CcSEcCtD
Bimatoprost—Palpitations—Phentermine—obesity	0.000702	0.00578	CcSEcCtD
Bimatoprost—Erythema—Diethylpropion—obesity	0.000691	0.00569	CcSEcCtD
Bimatoprost—Hypertension—Phentermine—obesity	0.000686	0.00565	CcSEcCtD
Bimatoprost—Cystitis noninfective—Bupropion—obesity	0.000685	0.00564	CcSEcCtD
Bimatoprost—Tension—Diethylpropion—obesity	0.000678	0.00558	CcSEcCtD
Bimatoprost—Cystitis—Bupropion—obesity	0.000677	0.00557	CcSEcCtD
Bimatoprost—Chest pain—Phentermine—obesity	0.000676	0.00557	CcSEcCtD
Bimatoprost—Nervousness—Diethylpropion—obesity	0.000671	0.00553	CcSEcCtD
Bimatoprost—Dry mouth—Phentermine—obesity	0.000662	0.00545	CcSEcCtD
Bimatoprost—Photophobia—Bupropion—obesity	0.000658	0.00542	CcSEcCtD
Bimatoprost—Vision blurred—Diethylpropion—obesity	0.000651	0.00536	CcSEcCtD
Bimatoprost—Dry eye—Bupropion—obesity	0.000647	0.00533	CcSEcCtD
Bimatoprost—Eye pain—Sibutramine—obesity	0.000646	0.00532	CcSEcCtD
Bimatoprost—Burning sensation—Topiramate—obesity	0.000643	0.00529	CcSEcCtD
Bimatoprost—Bladder pain—Bupropion—obesity	0.000634	0.00522	CcSEcCtD
Bimatoprost—Arthritis—Orlistat—obesity	0.00062	0.00511	CcSEcCtD
Bimatoprost—Insomnia—Phenylpropanolamine—obesity	0.000613	0.00505	CcSEcCtD
Bimatoprost—Palpitations—Diethylpropion—obesity	0.000611	0.00503	CcSEcCtD
Bimatoprost—Dyspnoea—Phenylpropanolamine—obesity	0.000604	0.00497	CcSEcCtD
Bimatoprost—Somnolence—Phenylpropanolamine—obesity	0.000602	0.00496	CcSEcCtD
Bimatoprost—Arthritis—Sibutramine—obesity	0.0006	0.00494	CcSEcCtD
Bimatoprost—Dizziness—Methamphetamine—obesity	0.000597	0.00491	CcSEcCtD
Bimatoprost—Chest pain—Diethylpropion—obesity	0.000588	0.00484	CcSEcCtD
Bimatoprost—Scotoma—Topiramate—obesity	0.000588	0.00484	CcSEcCtD
Bimatoprost—Insomnia—Phentermine—obesity	0.000587	0.00483	CcSEcCtD
Bimatoprost—Anxiety—Diethylpropion—obesity	0.000586	0.00483	CcSEcCtD
Bimatoprost—Dizziness—Benzphetamine—obesity	0.000576	0.00474	CcSEcCtD
Bimatoprost—Dry mouth—Diethylpropion—obesity	0.000576	0.00474	CcSEcCtD
Bimatoprost—Dyspepsia—Phentermine—obesity	0.000571	0.0047	CcSEcCtD
Bimatoprost—Headache—Methamphetamine—obesity	0.000565	0.00465	CcSEcCtD
Bimatoprost—Eye pain—Bupropion—obesity	0.000564	0.00464	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Phentermine—obesity	0.00056	0.00461	CcSEcCtD
Bimatoprost—Anxiety—Cimetidine—obesity	0.000558	0.00459	CcSEcCtD
Bimatoprost—Dry skin—Orlistat—obesity	0.000553	0.00455	CcSEcCtD
Bimatoprost—Headache—Benzphetamine—obesity	0.000545	0.00449	CcSEcCtD
Bimatoprost—Liver function test abnormal—Sibutramine—obesity	0.000539	0.00443	CcSEcCtD
Bimatoprost—Visual disturbance—Bupropion—obesity	0.000537	0.00442	CcSEcCtD
Bimatoprost—Dry skin—Sibutramine—obesity	0.000535	0.0044	CcSEcCtD
Bimatoprost—Dizziness—Phendimetrazine—obesity	0.000525	0.00432	CcSEcCtD
Bimatoprost—Arthritis—Bupropion—obesity	0.000523	0.00431	CcSEcCtD
Bimatoprost—Asthma—Orlistat—obesity	0.000521	0.00429	CcSEcCtD
Bimatoprost—Nausea—Benzphetamine—obesity	0.000517	0.00426	CcSEcCtD
Bimatoprost—Insomnia—Diethylpropion—obesity	0.00051	0.0042	CcSEcCtD
Bimatoprost—Diplopia—Bupropion—obesity	0.000509	0.00419	CcSEcCtD
Bimatoprost—Asthma—Sibutramine—obesity	0.000504	0.00415	CcSEcCtD
Bimatoprost—Dyspnoea—Diethylpropion—obesity	0.000503	0.00414	CcSEcCtD
Bimatoprost—Somnolence—Diethylpropion—obesity	0.000502	0.00413	CcSEcCtD
Bimatoprost—Headache—Phendimetrazine—obesity	0.000497	0.00409	CcSEcCtD
Bimatoprost—Dyspepsia—Diethylpropion—obesity	0.000497	0.00409	CcSEcCtD
Bimatoprost—Skin discolouration—Topiramate—obesity	0.000494	0.00407	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Diethylpropion—obesity	0.000487	0.00401	CcSEcCtD
Bimatoprost—Bronchitis—Sibutramine—obesity	0.000485	0.00399	CcSEcCtD
Bimatoprost—Lacrimation increased—Topiramate—obesity	0.000484	0.00399	CcSEcCtD
Bimatoprost—Tafluprost—PTGS2—obesity	0.000484	0.196	CrCbGaD
Bimatoprost—Upper respiratory tract infection—Orlistat—obesity	0.000484	0.00399	CcSEcCtD
Bimatoprost—Somnolence—Cimetidine—obesity	0.000477	0.00393	CcSEcCtD
Bimatoprost—Nausea—Phendimetrazine—obesity	0.000471	0.00388	CcSEcCtD
Bimatoprost—Dry skin—Bupropion—obesity	0.000466	0.00384	CcSEcCtD
Bimatoprost—Asthenia—Phentermine—obesity	0.000465	0.00383	CcSEcCtD
Bimatoprost—Depression—Orlistat—obesity	0.000463	0.00381	CcSEcCtD
Bimatoprost—Nasopharyngitis—Bupropion—obesity	0.000455	0.00374	CcSEcCtD
Bimatoprost—Depression—Sibutramine—obesity	0.000448	0.00369	CcSEcCtD
Bimatoprost—Dizziness—Phenylpropanolamine—obesity	0.000448	0.00369	CcSEcCtD
Bimatoprost—Dinoprostone—SLC22A1—obesity	0.000446	0.181	CrCbGaD
Bimatoprost—Asthma—Bupropion—obesity	0.00044	0.00362	CcSEcCtD
Bimatoprost—Cystitis noninfective—Topiramate—obesity	0.000436	0.00359	CcSEcCtD
Bimatoprost—Sinusitis—Orlistat—obesity	0.000436	0.00359	CcSEcCtD
Bimatoprost—Cystitis—Topiramate—obesity	0.000431	0.00355	CcSEcCtD
Bimatoprost—Dizziness—Phentermine—obesity	0.000429	0.00353	CcSEcCtD
Bimatoprost—Rash—Phenylpropanolamine—obesity	0.000427	0.00352	CcSEcCtD
Bimatoprost—Dermatitis—Phenylpropanolamine—obesity	0.000427	0.00351	CcSEcCtD
Bimatoprost—Bronchitis—Bupropion—obesity	0.000423	0.00348	CcSEcCtD
Bimatoprost—Sinusitis—Sibutramine—obesity	0.000422	0.00347	CcSEcCtD
Bimatoprost—Photophobia—Topiramate—obesity	0.000419	0.00345	CcSEcCtD
Bimatoprost—Pharyngitis—Orlistat—obesity	0.000414	0.00341	CcSEcCtD
Bimatoprost—Dry eye—Topiramate—obesity	0.000412	0.00339	CcSEcCtD
Bimatoprost—Oedema peripheral—Orlistat—obesity	0.000411	0.00338	CcSEcCtD
Bimatoprost—Rash—Phentermine—obesity	0.000409	0.00337	CcSEcCtD
Bimatoprost—Upper respiratory tract infection—Bupropion—obesity	0.000409	0.00336	CcSEcCtD
Bimatoprost—Dermatitis—Phentermine—obesity	0.000409	0.00336	CcSEcCtD
Bimatoprost—Headache—Phentermine—obesity	0.000406	0.00334	CcSEcCtD
Bimatoprost—Rhinitis—Sibutramine—obesity	0.000405	0.00333	CcSEcCtD
Bimatoprost—Bladder pain—Topiramate—obesity	0.000404	0.00332	CcSEcCtD
Bimatoprost—Nausea—Phenylpropanolamine—obesity	0.000403	0.00331	CcSEcCtD
Bimatoprost—Pharyngitis—Sibutramine—obesity	0.000401	0.0033	CcSEcCtD
Bimatoprost—Oedema peripheral—Sibutramine—obesity	0.000398	0.00327	CcSEcCtD
Bimatoprost—Visual impairment—Sibutramine—obesity	0.000389	0.0032	CcSEcCtD
Bimatoprost—Nausea—Phentermine—obesity	0.000385	0.00317	CcSEcCtD
Bimatoprost—Asthenia—Cimetidine—obesity	0.000385	0.00317	CcSEcCtD
Bimatoprost—Eye disorder—Sibutramine—obesity	0.000377	0.00311	CcSEcCtD
Bimatoprost—Mediastinal disorder—Orlistat—obesity	0.000376	0.00309	CcSEcCtD
Bimatoprost—Dizziness—Diethylpropion—obesity	0.000373	0.00307	CcSEcCtD
Bimatoprost—Sinusitis—Bupropion—obesity	0.000368	0.00303	CcSEcCtD
Bimatoprost—Angiopathy—Sibutramine—obesity	0.000366	0.00302	CcSEcCtD
Bimatoprost—Eye pain—Topiramate—obesity	0.000359	0.00296	CcSEcCtD
Bimatoprost—Rash—Diethylpropion—obesity	0.000356	0.00293	CcSEcCtD
Bimatoprost—Dermatitis—Diethylpropion—obesity	0.000355	0.00293	CcSEcCtD
Bimatoprost—Dizziness—Cimetidine—obesity	0.000355	0.00292	CcSEcCtD
Bimatoprost—Headache—Diethylpropion—obesity	0.000353	0.00291	CcSEcCtD
Bimatoprost—Rhinitis—Bupropion—obesity	0.000353	0.0029	CcSEcCtD
Bimatoprost—Pharyngitis—Bupropion—obesity	0.000349	0.00288	CcSEcCtD
Bimatoprost—Oedema peripheral—Bupropion—obesity	0.000347	0.00285	CcSEcCtD
Bimatoprost—Connective tissue disorder—Bupropion—obesity	0.000346	0.00285	CcSEcCtD
Bimatoprost—Tension—Sibutramine—obesity	0.000345	0.00284	CcSEcCtD
Bimatoprost—Vision blurred—Orlistat—obesity	0.000342	0.00282	CcSEcCtD
Bimatoprost—Visual disturbance—Topiramate—obesity	0.000342	0.00282	CcSEcCtD
Bimatoprost—Nervousness—Sibutramine—obesity	0.000341	0.00281	CcSEcCtD
Bimatoprost—Visual impairment—Bupropion—obesity	0.000339	0.00279	CcSEcCtD
Bimatoprost—Rash—Cimetidine—obesity	0.000338	0.00279	CcSEcCtD
Bimatoprost—Dermatitis—Cimetidine—obesity	0.000338	0.00278	CcSEcCtD
Bimatoprost—Headache—Cimetidine—obesity	0.000336	0.00277	CcSEcCtD
Bimatoprost—Nausea—Diethylpropion—obesity	0.000335	0.00276	CcSEcCtD
Bimatoprost—Dinoprostone—CYP19A1—obesity	0.000332	0.134	CrCbGaD
Bimatoprost—Vision blurred—Sibutramine—obesity	0.000331	0.00273	CcSEcCtD
Bimatoprost—Eye disorder—Bupropion—obesity	0.000329	0.00271	CcSEcCtD
Bimatoprost—Vertigo—Orlistat—obesity	0.000326	0.00269	CcSEcCtD
Bimatoprost—Diplopia—Topiramate—obesity	0.000324	0.00267	CcSEcCtD
Bimatoprost—Palpitations—Orlistat—obesity	0.000321	0.00264	CcSEcCtD
Bimatoprost—Angiopathy—Bupropion—obesity	0.000319	0.00263	CcSEcCtD
Bimatoprost—Nausea—Cimetidine—obesity	0.000319	0.00262	CcSEcCtD
Bimatoprost—Mediastinal disorder—Bupropion—obesity	0.000317	0.00261	CcSEcCtD
Bimatoprost—Cough—Orlistat—obesity	0.000317	0.00261	CcSEcCtD
Bimatoprost—Vertigo—Sibutramine—obesity	0.000316	0.0026	CcSEcCtD
Bimatoprost—Palpitations—Sibutramine—obesity	0.000311	0.00256	CcSEcCtD
Bimatoprost—Chest pain—Orlistat—obesity	0.000309	0.00254	CcSEcCtD
Bimatoprost—Anxiety—Orlistat—obesity	0.000308	0.00254	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.000307	0.00253	CcSEcCtD
Bimatoprost—Cough—Sibutramine—obesity	0.000307	0.00252	CcSEcCtD
Bimatoprost—Hypertension—Sibutramine—obesity	0.000303	0.0025	CcSEcCtD
Bimatoprost—Dry mouth—Orlistat—obesity	0.000302	0.00249	CcSEcCtD
Bimatoprost—Tension—Bupropion—obesity	0.000301	0.00247	CcSEcCtD
Bimatoprost—Liver function test abnormal—Topiramate—obesity	0.000299	0.00246	CcSEcCtD
Bimatoprost—Chest pain—Sibutramine—obesity	0.000299	0.00246	CcSEcCtD
Bimatoprost—Anxiety—Sibutramine—obesity	0.000298	0.00245	CcSEcCtD
Bimatoprost—Nervousness—Bupropion—obesity	0.000298	0.00245	CcSEcCtD
Bimatoprost—Infection—Orlistat—obesity	0.000294	0.00242	CcSEcCtD
Bimatoprost—Dry mouth—Sibutramine—obesity	0.000293	0.00241	CcSEcCtD
Bimatoprost—Nervous system disorder—Orlistat—obesity	0.000291	0.00239	CcSEcCtD
Bimatoprost—Nasopharyngitis—Topiramate—obesity	0.00029	0.00239	CcSEcCtD
Bimatoprost—Vision blurred—Bupropion—obesity	0.000289	0.00238	CcSEcCtD
Bimatoprost—Skin disorder—Orlistat—obesity	0.000288	0.00237	CcSEcCtD
Bimatoprost—Infection—Sibutramine—obesity	0.000285	0.00235	CcSEcCtD
Bimatoprost—Asthma—Topiramate—obesity	0.00028	0.00231	CcSEcCtD
Bimatoprost—Skin disorder—Sibutramine—obesity	0.000279	0.00229	CcSEcCtD
Bimatoprost—Vertigo—Bupropion—obesity	0.000275	0.00227	CcSEcCtD
Bimatoprost—Palpitations—Bupropion—obesity	0.000271	0.00223	CcSEcCtD
Bimatoprost—Bronchitis—Topiramate—obesity	0.000269	0.00222	CcSEcCtD
Bimatoprost—Insomnia—Orlistat—obesity	0.000268	0.00221	CcSEcCtD
Bimatoprost—Cough—Bupropion—obesity	0.000267	0.0022	CcSEcCtD
Bimatoprost—Hypertension—Bupropion—obesity	0.000265	0.00218	CcSEcCtD
Bimatoprost—Dyspepsia—Orlistat—obesity	0.000261	0.00215	CcSEcCtD
Bimatoprost—Chest pain—Bupropion—obesity	0.000261	0.00215	CcSEcCtD
Bimatoprost—Upper respiratory tract infection—Topiramate—obesity	0.00026	0.00214	CcSEcCtD
Bimatoprost—Anxiety—Bupropion—obesity	0.00026	0.00214	CcSEcCtD
Bimatoprost—Insomnia—Sibutramine—obesity	0.000259	0.00214	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.000259	0.00213	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Orlistat—obesity	0.000256	0.00211	CcSEcCtD
Bimatoprost—Dyspnoea—Sibutramine—obesity	0.000256	0.0021	CcSEcCtD
Bimatoprost—Dry mouth—Bupropion—obesity	0.000255	0.0021	CcSEcCtD
Bimatoprost—Somnolence—Sibutramine—obesity	0.000255	0.0021	CcSEcCtD
Bimatoprost—Pain—Orlistat—obesity	0.000253	0.00209	CcSEcCtD
Bimatoprost—Dyspepsia—Sibutramine—obesity	0.000252	0.00208	CcSEcCtD
Bimatoprost—Depression—Topiramate—obesity	0.000249	0.00205	CcSEcCtD
Bimatoprost—Infection—Bupropion—obesity	0.000248	0.00204	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Sibutramine—obesity	0.000248	0.00204	CcSEcCtD
Bimatoprost—Pain—Sibutramine—obesity	0.000245	0.00202	CcSEcCtD
Bimatoprost—Nervous system disorder—Bupropion—obesity	0.000245	0.00202	CcSEcCtD
Bimatoprost—Skin disorder—Bupropion—obesity	0.000243	0.002	CcSEcCtD
Bimatoprost—Sinusitis—Topiramate—obesity	0.000234	0.00193	CcSEcCtD
Bimatoprost—Insomnia—Bupropion—obesity	0.000226	0.00186	CcSEcCtD
Bimatoprost—Rhinitis—Topiramate—obesity	0.000225	0.00185	CcSEcCtD
Bimatoprost—Dyspnoea—Bupropion—obesity	0.000223	0.00183	CcSEcCtD
Bimatoprost—Pharyngitis—Topiramate—obesity	0.000223	0.00183	CcSEcCtD
Bimatoprost—Somnolence—Bupropion—obesity	0.000222	0.00183	CcSEcCtD
Bimatoprost—Oedema peripheral—Topiramate—obesity	0.000221	0.00182	CcSEcCtD
Bimatoprost—Connective tissue disorder—Topiramate—obesity	0.00022	0.00181	CcSEcCtD
Bimatoprost—Dyspepsia—Bupropion—obesity	0.00022	0.00181	CcSEcCtD
Bimatoprost—Visual impairment—Topiramate—obesity	0.000216	0.00178	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Bupropion—obesity	0.000216	0.00178	CcSEcCtD
Bimatoprost—Pain—Bupropion—obesity	0.000214	0.00176	CcSEcCtD
Bimatoprost—Asthenia—Orlistat—obesity	0.000213	0.00175	CcSEcCtD
Bimatoprost—Pruritus—Orlistat—obesity	0.00021	0.00173	CcSEcCtD
Bimatoprost—Eye disorder—Topiramate—obesity	0.00021	0.00172	CcSEcCtD
Bimatoprost—Asthenia—Sibutramine—obesity	0.000206	0.00169	CcSEcCtD
Bimatoprost—Angiopathy—Topiramate—obesity	0.000203	0.00167	CcSEcCtD
Bimatoprost—Pruritus—Sibutramine—obesity	0.000203	0.00167	CcSEcCtD
Bimatoprost—Mediastinal disorder—Topiramate—obesity	0.000202	0.00166	CcSEcCtD
Bimatoprost—Dizziness—Orlistat—obesity	0.000196	0.00161	CcSEcCtD
Bimatoprost—Erythema—Topiramate—obesity	0.000195	0.00161	CcSEcCtD
Bimatoprost—Tension—Topiramate—obesity	0.000192	0.00158	CcSEcCtD
Bimatoprost—Dizziness—Sibutramine—obesity	0.00019	0.00156	CcSEcCtD
Bimatoprost—Nervousness—Topiramate—obesity	0.00019	0.00156	CcSEcCtD
Bimatoprost—Rash—Orlistat—obesity	0.000187	0.00154	CcSEcCtD
Bimatoprost—Dermatitis—Orlistat—obesity	0.000187	0.00154	CcSEcCtD
Bimatoprost—Headache—Orlistat—obesity	0.000186	0.00153	CcSEcCtD
Bimatoprost—Vision blurred—Topiramate—obesity	0.000184	0.00151	CcSEcCtD
Bimatoprost—Rash—Sibutramine—obesity	0.000181	0.00149	CcSEcCtD
Bimatoprost—Dermatitis—Sibutramine—obesity	0.000181	0.00149	CcSEcCtD
Bimatoprost—Headache—Sibutramine—obesity	0.00018	0.00148	CcSEcCtD
Bimatoprost—Asthenia—Bupropion—obesity	0.000179	0.00148	CcSEcCtD
Bimatoprost—Pruritus—Bupropion—obesity	0.000177	0.00146	CcSEcCtD
Bimatoprost—Nausea—Orlistat—obesity	0.000176	0.00145	CcSEcCtD
Bimatoprost—Vertigo—Topiramate—obesity	0.000175	0.00144	CcSEcCtD
Bimatoprost—Palpitations—Topiramate—obesity	0.000172	0.00142	CcSEcCtD
Bimatoprost—Nausea—Sibutramine—obesity	0.00017	0.0014	CcSEcCtD
Bimatoprost—Cough—Topiramate—obesity	0.00017	0.0014	CcSEcCtD
Bimatoprost—Hypertension—Topiramate—obesity	0.000169	0.00139	CcSEcCtD
Bimatoprost—Chest pain—Topiramate—obesity	0.000166	0.00137	CcSEcCtD
Bimatoprost—Anxiety—Topiramate—obesity	0.000166	0.00136	CcSEcCtD
Bimatoprost—Dizziness—Bupropion—obesity	0.000165	0.00136	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	0.000165	0.00136	CcSEcCtD
Bimatoprost—Dry mouth—Topiramate—obesity	0.000163	0.00134	CcSEcCtD
Bimatoprost—Infection—Topiramate—obesity	0.000158	0.0013	CcSEcCtD
Bimatoprost—Rash—Bupropion—obesity	0.000158	0.0013	CcSEcCtD
Bimatoprost—Dermatitis—Bupropion—obesity	0.000158	0.0013	CcSEcCtD
Bimatoprost—Headache—Bupropion—obesity	0.000157	0.00129	CcSEcCtD
Bimatoprost—Nervous system disorder—Topiramate—obesity	0.000156	0.00129	CcSEcCtD
Bimatoprost—Skin disorder—Topiramate—obesity	0.000155	0.00127	CcSEcCtD
Bimatoprost—Nausea—Bupropion—obesity	0.000149	0.00122	CcSEcCtD
Bimatoprost—Insomnia—Topiramate—obesity	0.000144	0.00119	CcSEcCtD
Bimatoprost—Dyspnoea—Topiramate—obesity	0.000142	0.00117	CcSEcCtD
Bimatoprost—Somnolence—Topiramate—obesity	0.000142	0.00117	CcSEcCtD
Bimatoprost—Dyspepsia—Topiramate—obesity	0.00014	0.00115	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Topiramate—obesity	0.000138	0.00113	CcSEcCtD
Bimatoprost—Pain—Topiramate—obesity	0.000136	0.00112	CcSEcCtD
Bimatoprost—Asthenia—Topiramate—obesity	0.000114	0.000941	CcSEcCtD
Bimatoprost—Pruritus—Topiramate—obesity	0.000113	0.000928	CcSEcCtD
Bimatoprost—Dizziness—Topiramate—obesity	0.000105	0.000867	CcSEcCtD
Bimatoprost—Rash—Topiramate—obesity	0.0001	0.000827	CcSEcCtD
Bimatoprost—Dermatitis—Topiramate—obesity	0.0001	0.000826	CcSEcCtD
Bimatoprost—Headache—Topiramate—obesity	9.98e-05	0.000821	CcSEcCtD
Bimatoprost—Nausea—Topiramate—obesity	9.46e-05	0.000779	CcSEcCtD
Bimatoprost—PTGER1—Signaling by GPCR—AKT2—obesity	1.96e-05	0.000122	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—PIK3R1—obesity	1.96e-05	0.000122	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—IRS2—obesity	1.96e-05	0.000122	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—AGT—obesity	1.95e-05	0.000122	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—SOCS1—obesity	1.94e-05	0.000121	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—FOXO3—obesity	1.93e-05	0.000121	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—STK11—obesity	1.93e-05	0.000121	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—APOE—obesity	1.93e-05	0.000121	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—LPL—obesity	1.93e-05	0.000121	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—ADRB2—obesity	1.93e-05	0.00012	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—PIK3CD—obesity	1.92e-05	0.00012	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—SOCS3—obesity	1.91e-05	0.00012	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—LEP—obesity	1.91e-05	0.00012	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—APOE—obesity	1.91e-05	0.00012	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—CAV1—obesity	1.91e-05	0.00012	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—PLG—obesity	1.91e-05	0.000119	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—APOA1—obesity	1.91e-05	0.000119	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—SOCS1—obesity	1.9e-05	0.000119	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CAV1—obesity	1.9e-05	0.000119	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—APOA1—obesity	1.89e-05	0.000118	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—PIK3CD—obesity	1.88e-05	0.000118	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—GPX1—obesity	1.88e-05	0.000118	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—GNB3—obesity	1.87e-05	0.000117	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—SOCS3—obesity	1.87e-05	0.000117	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—FOXO3—obesity	1.86e-05	0.000117	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—ADRB2—obesity	1.86e-05	0.000116	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—TYK2—obesity	1.85e-05	0.000116	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—PIK3CB—obesity	1.84e-05	0.000115	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—IGF2—obesity	1.84e-05	0.000115	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—GNB3—obesity	1.84e-05	0.000115	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—RHOA—obesity	1.83e-05	0.000115	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—CD36—obesity	1.83e-05	0.000115	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—SOCS1—obesity	1.83e-05	0.000114	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—ESR1—obesity	1.83e-05	0.000114	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—GNAS—obesity	1.83e-05	0.000114	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—PIK3R1—obesity	1.81e-05	0.000113	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—TYK2—obesity	1.81e-05	0.000113	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—SOCS3—obesity	1.81e-05	0.000113	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—PIK3CB—obesity	1.81e-05	0.000113	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—F2—obesity	1.8e-05	0.000113	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—PRKCB—obesity	1.8e-05	0.000113	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—IGF2—obesity	1.8e-05	0.000113	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—BAD—obesity	1.8e-05	0.000112	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—RHOA—obesity	1.79e-05	0.000112	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—APOB—obesity	1.79e-05	0.000112	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—GNAS—obesity	1.79e-05	0.000112	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—BAD—obesity	1.78e-05	0.000111	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—PIK3R1—obesity	1.78e-05	0.000111	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—GNB3—obesity	1.77e-05	0.000111	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—APOB—obesity	1.75e-05	0.000109	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CCL5—obesity	1.75e-05	0.000109	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—IGF2—obesity	1.74e-05	0.000109	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—MTHFR—obesity	1.74e-05	0.000109	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—PIK3CG—obesity	1.73e-05	0.000108	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—GNAS—obesity	1.72e-05	0.000108	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—IRS1—obesity	1.72e-05	0.000108	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CCL5—obesity	1.71e-05	0.000107	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—IRS1—obesity	1.71e-05	0.000107	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—LPL—obesity	1.71e-05	0.000107	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—PPARA—obesity	1.7e-05	0.000106	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—FOXO1—obesity	1.69e-05	0.000106	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—RPS6KB1—obesity	1.69e-05	0.000106	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—APOB—obesity	1.69e-05	0.000106	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—PIK3CB—obesity	1.67e-05	0.000105	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—LPL—obesity	1.67e-05	0.000104	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—FOXO1—obesity	1.66e-05	0.000104	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—RPS6KB1—obesity	1.66e-05	0.000104	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—AGT—obesity	1.65e-05	0.000103	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CCL5—obesity	1.65e-05	0.000103	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—INS—obesity	1.65e-05	0.000103	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—POMC—obesity	1.64e-05	0.000103	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—PIK3CB—obesity	1.64e-05	0.000103	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—INS—obesity	1.63e-05	0.000102	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—APOE—obesity	1.62e-05	0.000101	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—LPL—obesity	1.61e-05	0.000101	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CCL2—obesity	1.61e-05	0.000101	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—CAV1—obesity	1.6e-05	0.0001	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—FOXO1—obesity	1.6e-05	0.0001	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—RPS6KB1—obesity	1.6e-05	9.99e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—APOA1—obesity	1.6e-05	9.99e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—AKT2—obesity	1.59e-05	9.96e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—IGF1—obesity	1.58e-05	9.89e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—AKT2—obesity	1.58e-05	9.88e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—PRKCD—obesity	1.57e-05	9.83e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—PRKCD—obesity	1.54e-05	9.63e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—HTR2A—obesity	1.54e-05	9.62e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—C3—obesity	1.54e-05	9.61e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—PIK3CD—obesity	1.53e-05	9.57e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism of lipids and lipoproteins—PIK3CA—obesity	1.53e-05	9.56e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—PIK3CD—obesity	1.52e-05	9.49e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—SERPINE1—obesity	1.51e-05	9.47e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—HTR2A—obesity	1.51e-05	9.42e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—C3—obesity	1.5e-05	9.41e-05	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR downstream signaling—PIK3CA—obesity	1.5e-05	9.4e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—SERPINE1—obesity	1.5e-05	9.39e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—PRKCD—obesity	1.49e-05	9.29e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—TYK2—obesity	1.47e-05	9.21e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—IRS2—obesity	1.46e-05	9.14e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—RHOA—obesity	1.46e-05	9.13e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—TYK2—obesity	1.46e-05	9.13e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—AGT—obesity	1.46e-05	9.13e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—PIK3CG—obesity	1.46e-05	9.12e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—HTR2A—obesity	1.45e-05	9.09e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—C3—obesity	1.45e-05	9.08e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—RHOA—obesity	1.45e-05	9.06e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—PIK3R1—obesity	1.45e-05	9.04e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—NOS3—obesity	1.45e-05	9.04e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—PIK3R1—obesity	1.43e-05	8.96e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—NOS3—obesity	1.43e-05	8.96e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—IRS2—obesity	1.43e-05	8.95e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—APOE—obesity	1.43e-05	8.95e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—LEP—obesity	1.43e-05	8.95e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—AGT—obesity	1.43e-05	8.94e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CAV1—obesity	1.42e-05	8.86e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—APOA1—obesity	1.41e-05	8.84e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—PPARG—obesity	1.41e-05	8.8e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—LEP—obesity	1.4e-05	8.76e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—APOE—obesity	1.4e-05	8.76e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—POMC—obesity	1.39e-05	8.68e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CAV1—obesity	1.39e-05	8.68e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—APOA1—obesity	1.38e-05	8.66e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—IRS2—obesity	1.38e-05	8.63e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—INS—obesity	1.38e-05	8.63e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—AGT—obesity	1.38e-05	8.62e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—ESR1—obesity	1.37e-05	8.54e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—PIK3CA—obesity	1.37e-05	8.54e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—LEP—obesity	1.35e-05	8.45e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—APOE—obesity	1.35e-05	8.45e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—PRKCB—obesity	1.35e-05	8.44e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—F2—obesity	1.35e-05	8.44e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CAV1—obesity	1.34e-05	8.37e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—ESR1—obesity	1.34e-05	8.36e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—APOA1—obesity	1.34e-05	8.35e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—PIK3CB—obesity	1.33e-05	8.34e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—MTOR—obesity	1.33e-05	8.34e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—BAD—obesity	1.33e-05	8.34e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—PIK3CB—obesity	1.32e-05	8.27e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—MTOR—obesity	1.32e-05	8.27e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—PTGS2—obesity	1.32e-05	8.27e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—F2—obesity	1.32e-05	8.26e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—PRKCB—obesity	1.32e-05	8.26e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—BAD—obesity	1.3e-05	8.16e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—PIK3CG—obesity	1.29e-05	8.07e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—ESR1—obesity	1.29e-05	8.07e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—PIK3CD—obesity	1.28e-05	8.02e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—IRS1—obesity	1.28e-05	7.98e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—F2—obesity	1.27e-05	7.97e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—PRKCB—obesity	1.27e-05	7.97e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—ALB—obesity	1.27e-05	7.91e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—PIK3CG—obesity	1.26e-05	7.9e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—BAD—obesity	1.26e-05	7.87e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—IRS1—obesity	1.25e-05	7.81e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—POMC—obesity	1.23e-05	7.69e-05	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR downstream signaling—AKT1—obesity	1.23e-05	7.68e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—INS—obesity	1.22e-05	7.64e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—PIK3CG—obesity	1.22e-05	7.63e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—NOS3—obesity	1.21e-05	7.57e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—PIK3R1—obesity	1.21e-05	7.57e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—IL6—obesity	1.21e-05	7.56e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—IRS1—obesity	1.21e-05	7.54e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—POMC—obesity	1.2e-05	7.52e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CCL2—obesity	1.2e-05	7.52e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—INS—obesity	1.2e-05	7.48e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—IGF1—obesity	1.18e-05	7.39e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—AKT2—obesity	1.18e-05	7.39e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CCL2—obesity	1.18e-05	7.36e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—POMC—obesity	1.16e-05	7.26e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—IGF1—obesity	1.16e-05	7.24e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—AKT2—obesity	1.16e-05	7.23e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—INS—obesity	1.15e-05	7.22e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—MMP9—obesity	1.15e-05	7.19e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CCL2—obesity	1.14e-05	7.1e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—PIK3CD—obesity	1.14e-05	7.1e-05	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—PIK3CA—obesity	1.12e-05	7.03e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—SERPINE1—obesity	1.12e-05	7.02e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—MAPK8—obesity	1.12e-05	6.99e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—PIK3CB—obesity	1.12e-05	6.99e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—IGF1—obesity	1.12e-05	6.98e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—AKT2—obesity	1.12e-05	6.98e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—AKT1—obesity	1.12e-05	6.98e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—PIK3CD—obesity	1.11e-05	6.95e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—PTGS2—obesity	1.11e-05	6.92e-05	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—PIK3CA—obesity	1.1e-05	6.88e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—SERPINE1—obesity	1.1e-05	6.87e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—TYK2—obesity	1.09e-05	6.83e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—RHOA—obesity	1.08e-05	6.77e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—PIK3CD—obesity	1.07e-05	6.7e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—NOS3—obesity	1.07e-05	6.7e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—PIK3R1—obesity	1.07e-05	6.7e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—TYK2—obesity	1.07e-05	6.68e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—SERPINE1—obesity	1.06e-05	6.63e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—RHOA—obesity	1.06e-05	6.63e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—PIK3R1—obesity	1.05e-05	6.56e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—NOS3—obesity	1.05e-05	6.56e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—TYK2—obesity	1.03e-05	6.45e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—STAT3—obesity	1.03e-05	6.45e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—RHOA—obesity	1.02e-05	6.4e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—STAT3—obesity	1.02e-05	6.39e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—PIK3CA—obesity	1.02e-05	6.38e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—NOS3—obesity	1.01e-05	6.33e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—PIK3R1—obesity	1.01e-05	6.33e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—PIK3CA—obesity	9.99e-06	6.25e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—MTOR—obesity	9.89e-06	6.19e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—PIK3CB—obesity	9.89e-06	6.19e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—PIK3CB—obesity	9.68e-06	6.06e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—MTOR—obesity	9.68e-06	6.06e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—MYC—obesity	9.58e-06	5.99e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—TGFB1—obesity	9.56e-06	5.98e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—MYC—obesity	9.5e-06	5.94e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—TGFB1—obesity	9.48e-06	5.93e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—PIK3CB—obesity	9.34e-06	5.84e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—MTOR—obesity	9.34e-06	5.84e-05	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—AKT1—obesity	9.18e-06	5.74e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—IL6—obesity	9.04e-06	5.65e-05	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—AKT1—obesity	8.99e-06	5.62e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—IL6—obesity	8.85e-06	5.53e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—MMP9—obesity	8.6e-06	5.38e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—MMP9—obesity	8.42e-06	5.26e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—MAPK8—obesity	8.36e-06	5.23e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—AKT1—obesity	8.34e-06	5.22e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—MAPK8—obesity	8.19e-06	5.12e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—AKT1—obesity	8.16e-06	5.11e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—PIK3CA—obesity	8.13e-06	5.09e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—MMP9—obesity	8.12e-06	5.08e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—PIK3CA—obesity	8.07e-06	5.04e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—MAPK8—obesity	7.9e-06	4.94e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—STAT3—obesity	7.65e-06	4.78e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—STAT3—obesity	7.48e-06	4.68e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—STAT3—obesity	7.22e-06	4.52e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—IL6—obesity	7.2e-06	4.5e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—IL6—obesity	7.14e-06	4.47e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—MYC—obesity	7.1e-06	4.44e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—TGFB1—obesity	7.09e-06	4.43e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—MYC—obesity	6.95e-06	4.35e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—TGFB1—obesity	6.94e-06	4.34e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—PIK3CA—obesity	6.81e-06	4.26e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—MYC—obesity	6.71e-06	4.2e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—TGFB1—obesity	6.69e-06	4.19e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—AKT1—obesity	6.64e-06	4.16e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—AKT1—obesity	6.59e-06	4.12e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—PIK3CA—obesity	6.03e-06	3.77e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—PIK3CA—obesity	5.9e-06	3.69e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—PIK3CA—obesity	5.7e-06	3.56e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—AKT1—obesity	5.56e-06	3.48e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—IL6—obesity	5.34e-06	3.34e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—IL6—obesity	5.23e-06	3.27e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—IL6—obesity	5.04e-06	3.15e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—AKT1—obesity	4.93e-06	3.08e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—AKT1—obesity	4.82e-06	3.02e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—AKT1—obesity	4.65e-06	2.91e-05	CbGpPWpGaD
